Document:

Exhibit 10.9

 

INVESTMENT AGREEMENT

 

THIS INVESTMENT AGREEMENT (this “Agreement”),
dated as of August __, 2021, is by and among (i) Apeiron Capital Investment Corp., a Delaware corporation (the “SPAC”),
(ii) Apeiron Capital Sponsor, LLC, a Delaware limited liability company (the “Sponsor”), and (iii) _____________
(“Investor”). This Agreement may be executed by an investment manager on behalf of managed funds and/or accounts and for the
elimination of doubt such fund or account shall, severally and not jointly, be the Investor hereunder.

 

WHEREAS, in connection with the initial public
offering (the “IPO”) of units of the SPAC, Investor has expressed an interest in acquiring up to 1,485,000 units in the
IPO (the “IPO Units”), which shall not exceed 9.9% of the total outstanding shares of Class A common stock, par value
$0.001 per share (the “Class A Common Stock”), underlying the units (not including the over-allotment option) (the “IPO
Indication”), at a price of $10.00 per unit.

 

WHEREAS, the parties wish to enter into this Agreement
pursuant to which Investor will purchase from the Sponsor shares of Class B common stock, par value $0.001 per share, of the SPAC
(the “Founder Shares”) for the same value paid by the Sponsor, or approximately $0.006 per share.

 

NOW THEREFORE, the parties hereto hereby agree as follows:

 

Section 1.
Sale and Purchase.

 

		(a)	In connection with the IPO Indication, and subject to the satisfaction of the conditions set forth in Section 1(b), the Sponsor
hereby agrees to sell to Investor up to 100,000 Founder Shares (such shares, the “Transferred Shares”) for an aggregate purchase
price of up to $600.00 ($0.006 per share) (the “Transfer Price”) on the date of the closing of the IPO, and Investor hereby
agrees to purchase the Transferred Shares (the “Transfer”). Concurrently with the Transfer, in consideration for the transfer
of the Transferred Shares, Investor shall pay the Transfer Price to the Sponsor in immediately available funds.

 

		(b)	Subject to (i) the fulfillment by Investor (but only to the extent actually allocated to Investor by the underwriters) of the
IPO Indication (which shall include the acquisition of 100% of the units of the SPAC allocated to Investor by the underwriters in the
IPO, which number of allocated units shall not be greater than 9.9% of the IPO Units (exclusive of any units that may be issued pursuant
to the underwriters’ over-allotment option)) and (ii) Investor’s payment of the Transfer Price as contemplated by Section 1(a) of
this Agreement, the Transfer shall occur and be effective upon the closing of the IPO, automatically and without any action of any other
party hereto. In the event Investor is provided with the opportunity to participate in the over-allotment exercise or purchase more than
1,485,000 IPO Units (9.9% of the IPO Units), it shall first be provided with the opportunity to purchase additional Transferred Shares
in a manner proportional to any increase above 1,485,000 IPO Units at the Transfer Price. The Transferred Shares shall not be reduced
should the Investor be allocated less than the IPO Indication.

 

		(c)	Notwithstanding anything to the contrary herein, the number of Transferred Shares shall not be subject to share price vesting triggers,
cut-back, reduction, mandatory repurchase, redemption or forfeiture for any reason, including (i) transfer of the Founder Shares
to any person, (ii) downsizing of the IPO, (iii) failure of the underwriters to exercise their green shoe option, (iv) concessions
or “earn-out” triggers in connection with the negotiation of a Business Combination (as defined below) or any other reason,
(v) or any other modification, without the Investor’s prior written consent.

 

    

     

    

 

		(d)	The obligations of Investor hereunder are subject to there being no material change in structure, terms and conditions in the capital
structure the SPAC from that set forth in the Registration Statement on Form S-1 filed with the United States Securities and Exchange
Commission on August [●], 2021 (the “Registration Statement”).

 

Section 2.
Representations and Warranties of the SPAC. The SPAC hereby represents and warrants to Investor, as follows:

 

		(a)	The SPAC has full power and authority to execute and deliver this Agreement, to perform its obligations hereunder and to consummate
the transactions contemplated hereby.

 

		(b)	This Agreement has been duly and validly executed and delivered by the SPAC and constitutes a legal, valid and binding obligation
of the SPAC enforceable against the SPAC in accordance with its terms.

 

		(c)	The execution and delivery of this Agreement, the consummation of the transactions contemplated hereby and the performance of its
obligations hereunder will not materially conflict with, or result in any material violation of or default under, any agreement or other
instrument to which the SPAC is a party or by which the SPAC is bound, or any decree, order, statute, rule or regulation applicable
to the SPAC.

 

		(d)	The Founder Shares, when issued to the Sponsor, were validly issued, fully paid and non-assessable, free and clear of all liens or
other restrictions (other than those arising under applicable securities laws or as otherwise disclosed in the Registration Statement)
and were not issued in violation of, or subject to, any preemptive or similar rights.

 

Section 3.
Representations and Warranties of the Sponsor. The Sponsor hereby represents and warrants to Investor, as follows:

 

		(a)	The Sponsor has full power and authority to execute and deliver this Agreement, to perform its obligations hereunder and to consummate
the transactions contemplated hereby.

 

		(b)	This Agreement has been duly and validly executed and delivered by the Sponsor and constitutes a legal, valid and binding obligation
of the Sponsor enforceable against the Sponsor in accordance with its terms.

 

		(c)	The execution and delivery of this Agreement, the consummation of the transactions contemplated hereby and the performance of its
obligations hereunder will not materially conflict with, or result in any material violation of or default under, any agreement or other
instrument to which the Sponsor is a party or by which the Sponsor is bound, or any decree, order, statute, rule or regulation applicable
to the Sponsor.

 

		(d)	The terms set forth in this Agreement are as favorable to the Investor as the terms granted to all other investors entering into a
similar agreement to purchase Founder Shares of the SPAC in connection with expressing interest in the IPO, provided that the Investor
acknowledges that Founders Shares have been offered to the Sponsor, executive officers, advisors, directors and director nominees of the
SPAC in connection with their service and the Sponsor expressly reserves the right to issue membership interests in the Sponsor its sole
discretion.

 

    

     

    

 

		(e)	The Sponsor is the beneficial owner of the Transferred Shares. Except as described in this Agreement or in the Registration Statement,
there is no agreement, arrangement or understanding with any other person regarding the sale or transfer of any Transferred Shares, and
there exist no liens, pledges, security interests, claims, options, proxies, voting agreements, charges or encumbrances of any kind affecting
the Transferred Shares, other than any restrictions on transfer that may be imposed by any applicable statute, law, ordinance, regulation,
rule, code, order, common law, judgment, decree, other requirement or rule of law (“Applicable Law”) of any federal,
state, local or foreign government or political subdivision thereof, or any agency or instrumentality of such government or political
subdivision, or any self-regulated organization or other non-governmental regulatory authority or quasigovernmental authority, or any
arbitrator, court or tribunal of competent jurisdiction (a “Governmental Authority”). Upon transfer of the Transferred Shares
to the Investor at the closing of the IPO against payment of the Transfer Price, the Investor will acquire ownership of the Transferred
Shares, free and clear of all liens, pledges, security interests, claims, options, proxies, voting agreements, charges or encumbrances
of any kind affecting the Transferred Shares, other than any restrictions on transfer that may be imposed by Applicable Law.

 

Section 4.
Representations and Warranties of Investor. Investor hereby represents and warrants to the SPAC and the Sponsor, as follows:

 

		(a)	Investor has full power and authority to execute and deliver this Agreement and to perform its obligations hereunder.

 

		(b)	This Agreement has been duly and validly executed and delivered by Investor and constitutes a legal, valid and binding obligation
of Investor enforceable against Investor in accordance with its terms.

 

		(c)	The execution and delivery of this Agreement, the consummation of the transactions contemplated hereby and the performance of its
obligations hereunder will not materially conflict with, or result in any material violation of or default under, any agreement or other
instrument to which Investor is a party or by which Investor is bound, or any decree, order, statute, rule or regulation applicable
to Investor.

 

		(d)	Investor is an “accredited investor” as that term is defined in Regulation D promulgated under the Securities Act of 1933,
as amended.

 

    

     

    

 

Section 5.
Additional Agreements and Acknowledgements of Investor.

 

		(a)	Without the written consent of the SPAC and the Sponsor, the Investor agrees not to transfer, assign or sell any Transferred Shares
or the Class A Common Stock, issuable upon conversion of the Transferred Shares held by it until the earlier of (i) one year
after the date the SPAC consummates a Business Combination (as defined below) or (ii) subsequent to a Business Combination, (A) the
date on which the last reported sale price of the Class A Common Stock equals or exceeds $12.00 per share of stock (as adjusted for
stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period
commencing at least 180 days after the consummation of a Business Combination and (B) the date on which the SPAC consummates a subsequent
liquidation, merger, stock exchange or other similar transaction which results in all of the SPAC’s stockholders having the right
to exchange their Class A Common Stock for cash, securities or other property. The Transferred Shares directly or indirectly owned
by the Investor will not be subject to additional lock-ups other than detailed in this Section 5(a) or in the Registration Statement.
For the avoidance of doubt, this Section 5 shall not restrict the Investor from redeeming, transferring, assigning or selling any
Class A Common Stock or units acquired in the IPO or in the open market.

 

		(b)	Investor acknowledges that the SPAC was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock
purchase, reorganization or similar business combination with one or more business entities (a “Business Combination”). Investor
agrees that if the SPAC seeks stockholder approval of a proposed Business Combination, then in connection with such proposed Business
Combination, Investor shall vote all Transferred Shares in favor of such proposed Business Combination.

 

		(c)	Investor acknowledges that it is aware the SPAC will establish a trust account (the “Trust Account”) for the benefit of
its public stockholders upon the closing of the IPO. Investor agrees that it has no right, title, interest or claim of any kind in or
to any monies held in the Trust Account, or any other asset of the SPAC as a result of any liquidation of the SPAC with respect to the
Transferred Shares. Notwithstanding the foregoing, nothing shall prevent the Investor from seeking redemption from the Trust for any Class A
Common Stock it acquires in the IPO or in the open market in accordance with the terms and conditions applicable to the Class A Common
Stock and the IPO described in the Registration Statement.

 

		(d)	In connection with the IPO, the SPAC shall enter into a registration rights agreement (the “Registration Rights Agreement”)
with the Sponsor, Investor and certain other parties thereto in the form filed as an exhibit to the SPAC’s Registration Statement.
The Registration Rights Agreement shall provide Investor with registration rights with respect to the Transferred Shares that are no less
favorable to Investor than the registration rights of the Sponsor set forth therein.

 

Section 6.
Miscellaneous.

 

		(a)	Any notice or communication under this Agreement shall be in writing and given by (i) deposit in the United States mail, addressed
to the party to be notified, postage prepaid and registered or certified with return receipt requested, (ii) recognized courier or
overnight delivery service providing evidence of delivery, or (iii) transmission by hand delivery, electronic mail or facsimile,
if to the Sponsor, to: Apeiron Capital Sponsor, LLC, 175 Federal Street, Suite 875, Boston, Massachusetts 02110; if to the SPAC,
to: Apeiron Capital Investment Corp., 175 Federal Street, Suite 875, Boston, Massachusetts 02110; and, if to the Investor, at the
Investor’s address or contact information as set forth on the signature page attached hereto.

 

		(b)	This Agreement shall be governed by the internal laws (and not the law of conflicts) of the State of New York.

 

    

     

    

 

		(c)	This Agreement may not be amended, modified or waived without the written consent of the parties hereto.

 

		(d)	The rights and obligations under this Agreement may not be assigned by any party hereto without the prior written consent of the other
parties.

 

		(e)	From time to time, at the reasonable request of any of the other parties hereto, each party hereto shall execute and deliver such
additional documents and instruments and take such further lawful action as may be necessary to consummate and make effective, in the
most expeditious manner practicable, the transactions contemplated by this Agreement.

 

		(f)	Any term or provision of this Agreement which is invalid or unenforceable shall be ineffective to the extent of such invalidity or
unenforceability without rendering invalid or unenforceable the remaining rights of the person intended to be benefited by such provision
or any other provisions of this Agreement.

 

		(g)	This Agreement may be executed in two or more counterparts, each of which shall constitute an original, and all of which taken together
shall constitute one and the same instrument. Any signature page delivered by a facsimile machine or electronic mail shall be binding
to the same extent as an original signature page.

 

		(h)	Neither the SPAC nor Sponsor nor any affiliate thereof shall disclose the identity of Investor or its affiliates or principals (in
any regulatory filing or otherwise), except as required by Applicable Law or in connection with any inquiry by a Governmental Authority,
without the prior consent of Investor, which shall not be unreasonably withheld or delayed.

 

		(i)	This Agreement shall terminate on the earlier of (i) the expiration of the lock-up period, (ii) the liquidation of the SPAC
or (iii) October 31, 2021 if the IPO has not been completed by such date.

 

		(j)	In the case of a conflict between the terms of this Agreement and the Sponsor’s Limited Liability Company Operating Agreement
dated February 5, 2021, as amended, restated, supplemented, waived and otherwise modified from time to time in accordance with its
terms, this Agreement shall control.

 

* * * * *

 

[Signature page follows]

 

    

     

    

 

IN WITNESS WHEREOF, the undersigned have executed this Agreement as
of the date first written above.

 

	 	INVESTOR:
	 	 
	 	[●]
	 	 
	 	By:	 
	 	 
	 	Name:
	 	 
	 	Title:
	 	 
	 	Address:
	 	 
	 	 
	 	Phone:
	 	 
	 	Email:
	 	 
	 	SPAC:
	 	 
	 	APEIRON CAPITAL INVESTMENT
	 	 
	 	CORP.
	 	 
	 	By:	 
	 	 
	 	Name: Joel Shulman
	 	 
	 	Title: Chief Executive Officer
	 	 
	 	SPONSOR:
	 	 
	 	APEIRON CAPITAL SPONSOR, LLC
	 	 
	 	By: Joel Shulman, its managing
	 	 
	 	member
	 	 
	 	By:	               
	 	 
	 	Name: Joel Shulman
	 	 
	 	Title: Managing Member

 

[Signature Page to Investment Agreement]Exhibit 4.1

  

   

  

  
    TWELFTH SUPPLEMENTAL INDENTURE

    

    

    THIS TWELFTH SUPPLEMENTAL INDENTURE, dated as of August 25, 2021 (this “Twelfth
          Supplemental Indenture”), is by and among Northrop Grumman Systems Corporation, a Delaware corporation (the “Company”), The Bank of New York Mellon, as
      trustee under the indenture referred to below (the “Trustee”), and Northrop Grumman Corporation, a Delaware corporation (“NGC”).  Capitalized terms used but not defined herein shall have the meanings assigned to such terms in the Indenture (as defined below).

    

    

    WHEREAS, the Company and the Trustee are parties to that certain Indenture, dated as of May 1, 1986, between TRW Inc. and Mellon Bank, N.A., as
      trustee (the “Base Indenture” and, as supplemented by the First Supplemental Indenture thereto, dated as of August 24, 1989, between TRW Inc. and the Trustee (the “First Supplemental Indenture”), by the Eighth Supplemental Indenture thereto, dated as of March 27, 2003, by and among Northrop Grumman Space & Mission Systems Corp.
      (formerly TRW Inc.), Northrop Grumman Corporation and JPMorgan Chase Bank, as successor trustee (the “Eighth Supplemental Indenture”), by the Ninth Supplemental Indenture
      thereto, dated as of December 31, 2009, by and among Northrop Grumman Space & Mission Systems Corp. (formerly TRW Inc.), the Trustee, as successor trustee to JPMorgan Chase Bank and to Mellon Bank, N.A., Northrop Grumman Corporation and the
      Company (the “Ninth Supplemental Indenture”), by the Tenth Supplemental Indenture thereto, dated as of March 30, 2011, by and among the Company, the Trustee, as successor
      trustee to JPMorgan Chase Bank and to Mellon Bank, N.A., Titan II Inc. (formerly Northrop Grumman Corporation) and Titan Holdings II, L.P. (the “Tenth Supplemental Indenture”),

      and by the Eleventh Supplemental Indenture thereto, dated as of March 30, 2011, by and among the Company (successor-in-interest to Northrop Grumman Space & Mission Systems Corp. and TRW Inc.), the Trustee, as successor trustee to JPMorgan Chase
      Bank and to Mellon Bank, N.A., Titan Holdings II, L.P. and NGC (the “Eleventh Supplemental Indenture”), the “Indenture”);

    

    

    WHEREAS, there is currently $41,205,000 in aggregate principal amount of 6.650% Debentures due 2028 outstanding (the “Debentures”), which were issued pursuant to the terms of the Indenture;

    

    

    WHEREAS, Section 11.02 of the Base Indenture provides that, with the consent of the Holders of not less than 66 2/3% in principal amount of the
      Outstanding Securities of each series affected by such supplemental indenture, by act of said Holders delivered to the Company and the Trustee, the Company, when authorized by a Board Resolution, and the Trustee may enter into a supplemental
      indenture to the Indenture for the purpose of adding any provisions to or changing in any manner or eliminating any of the provisions of the Indenture, or of modifying in any manner the rights of the Holders of Securities of such series under the
      Indenture;

    

    

    WHEREAS, the Company desires and has requested the Trustee to join with it and NGC in entering into this Twelfth Supplemental Indenture for the
      purpose of amending the Indenture with respect to the Debentures in certain respects as permitted by Section 11.02 of the Base Indenture (collectively, the “Proposed Amendments”);

    
      
        

    

    
    

    

    WHEREAS, the Company has been soliciting consents to this Twelfth Supplemental Indenture upon the terms and subject to the conditions set forth in the
      Offering Memorandum and Consent Solicitation Statement (herein so called) dated August 2, 2021, and supplemented on August 16, 2021 (which, including any amendments, modifications or supplements thereto, governs the “Consent Solicitations” for the Debentures);

    

    

    WHEREAS, the Company has received the consent of the Holders of at least 66 2/3% in principal amount of the outstanding Debentures to effect the
      Proposed Amendments;

    

    

    WHEREAS, (a) pursuant to the guarantee dated as of March 27, 2003 (the “Guarantee”),

      Northrop Grumman Corporation initially guaranteed the obligations of the Company in respect of the Debentures in favor of the Trustee under the Indenture, (b) pursuant to the Tenth Supplemental Indenture, Titan Holdings II, L.P. assumed the
      obligations of Titan II Inc. (formerly known as Northrop Grumman Corporation) under the Guarantee and (c) pursuant to the Eleventh Supplemental Indenture, NGC assumed obligations of Titan Holdings II, L.P. under the Guarantee such that, as of the
      date hereof, NGC is the sole guarantor of the obligations of the Company in respect of the Debentures under the Guarantee; and

    

    

    WHEREAS, concurrently with entering into this Twelfth Supplemental Indenture, in accordance with Section 6 of the Guarantee, NGC, the Trustee and the
      Company are entering into the First Amendment to Guarantee dated as of the date hereof (the “Amendment to Guarantee”) in order to provide for the termination of the
      Guarantee on the terms and subject to the conditions set forth therein.

    

    

    NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, the
      parties hereto mutually covenant and agree for the equal and ratable benefit of the Holders of the Debentures as follows:

    

    

    1.          Amendments to Articles Five, Six, Seven and Twelve of the Base Indenture. (a) With respect to the Debentures, the Base Indenture is hereby amended by deleting the following Sections or clauses of the
        Base Indenture and all references and definitions to the extent solely related thereto in their entirety and replacing each Section or clause with “[Intentionally Omitted]”:

    

    

    Section 5.05—Limitation on Liens

    Section 5.06—Limitation on Sale and Leaseback

    Section 5.08—Annual Officers’ Certificate

    Section 6.03—Reports by Company

    Clauses (d), (e) and (f) of Section 7.01—Events of Default

    Clause (ii) of Section 12.01—Consolidations and Mergers of Company and Conveyances Permitted Subject to Certain Conditions

    

    

    	

          	(b)	
            References in the Indenture to the Sections or clauses amended in Section 1(a) above shall mean such Sections or clauses as amended by this Twelfth Supplemental Indenture.

          

    

    

    2.          Amendment to References to Guarantee. All references to the Guarantee in the Indenture and the Debentures, with respect to the Debentures, shall refer to such Guarantee as amended and terminated.

    
      - 2 -

      
        

    

    

    

    3.          Amendments to Debentures. The Debentures are hereby amended to modify or delete, as applicable, all provisions inconsistent with the amendments to the Indenture effected by this Twelfth Supplemental
        Indenture.

    

    

    4.          Acknowledgement of Trustee.  The Trustee hereby acknowledges receipt of the following documents pursuant to the provisions of the Indenture:

    

    

    	

          	(a)	
            A Board Resolution of the Company authorizing the execution of this Twelfth Supplemental Indenture, as required by Section 11.02 of the Base Indenture.

          

    

    

    	

          	(b)	
            A Board Resolution of NGC authorizing the execution of this Twelfth Supplemental Indenture.

          

    

    

    	

          	(c)	
            An Officers’ Certificate of the Company as required by Section 15.05 of the Base Indenture.

          

    

    

    	

          	(d)	
            An Opinion of Counsel as required by Sections 11.03 and 15.05 of the Base Indenture.

          

    

    

    5.          Effectiveness. The provisions of this Twelfth Supplemental Indenture shall be effective only upon execution and delivery of this instrument by each of the parties hereto. Notwithstanding the
        foregoing sentence, the provisions of Section 1, Section 2 and Section 3 of this Twelfth Supplemental Indenture shall become operative at such time and date (the “Operative Date”)

        upon which NGC has accepted for exchange, and provided the applicable Total Exchange Consideration or Exchange Consideration, as the case may be, to all Holders of Debentures that have been validly tendered (and not validly withdrawn) pursuant to
        the terms of the Exchange Offer (as defined in the Offering Memorandum and Consent Solicitation Statement) with respect to the Debentures, with the result that the amendments to the Indenture effected by this Twelfth Supplemental Indenture shall be
        deemed to be revoked retroactive to the date hereof if the Operative Date shall not occur. The Company and NGC shall notify the Trustee promptly after the occurrence of the Operative Date or promptly after the Company and NGC shall determine that
        the Operative Date will not occur.

    

    

    6.          Endorsement and Change of Form of Debentures. Any Debentures authenticated and delivered after the close of business on the date that this Twelfth Supplemental Indenture becomes operative in
        substitution for Debentures then outstanding and all Debentures presented or delivered to the Trustee on and after that date for such purpose shall be stamped, imprinted or otherwise legended by the Company, with a notation as follows:

    

    

    “Effective as of August 25, 2021, certain restrictive covenants of the Company and certain Events of Default have been eliminated or limited, as
      provided in the Twelfth Supplemental Indenture, dated as of August 25, 2021. Reference is hereby made to such Twelfth Supplemental Indenture, copies of which are on file with the Trustee, for a description of the amendments made therein.”

    

    

    7.          Ratification. This Twelfth Supplemental Indenture is supplemental to the Indenture and shall form a part thereof. Other than as amended by this Twelfth Supplemental Indenture, the Indenture is hereby
        ratified, approved, and confirmed. In the event of any conflict between the terms of the Indenture and this Twelfth Supplemental Indenture, the terms of this Twelfth Supplemental Indenture shall prevail.

    
      - 3 -

      
        

    

    

    

    8.          Effect of Headings. The headings herein are for convenience of reference only, are not to be considered a part hereof, and shall not affect the construction hereof.

    

    

    9.          Successors and Assigns. All covenants and agreements in this Twelfth Supplemental Indenture by the Company and NGC shall bind their successors and assigns, whether so expressed or not.

    

    

    10.          Separability Clause. In case any provision in this Twelfth Supplemental Indenture shall be invalid, illegal or unenforceable, the validity, legality, and enforceability of the remaining provisions
        shall not in any way be affected or impaired thereby.

    

    

    11.          Governing Law. This Twelfth Supplemental Indenture shall be governed by, and construed in accordance with, the law of the State of New York, without regard to principles of conflicts of laws.

    

    

    12.          Counterpart Originals. This Twelfth Supplemental Indenture may be simultaneously executed in several counterparts, each of which shall be deemed to be an original, and such counterparts shall
        together constitute one and the same instrument. The words “execution,” “signed,” “signature,” “delivery,” and words of like import in or relating to this Twelfth Supplemental Indenture or any document to be signed in connection with this Twelfth
        Supplemental Indenture shall be deemed to include electronic signatures, deliveries or the keeping of records in electronic form, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature, physical
        delivery thereof or the use of a paper-based recordkeeping system, as the case may be, and the parties hereto consent to conduct the transactions contemplated hereunder by electronic means.

    

    

    13.          Additional Supplemental Indentures. Nothing contained herein shall impair the rights of the parties to enter into one or more additional supplemental indentures in the manner provided in the
        Indenture.

    

    

    14.          Trustee. In carrying out the Trustee’s responsibilities hereunder, the Trustee shall have all of the rights, protections and immunities which it possesses under the Indenture.  The Trustee makes no
        representations as to the validity or sufficiency of this Twelfth Supplemental Indenture.  The recitals and statements herein are deemed to be those of the Company and NGC and not of the Trustee.

    

    

    15.          Benefits. Nothing in this Twelfth Supplemental Indenture, express or implied, shall give to any Person, other than the parties hereto and their successors and the Holders, any benefit or any legal or
        equitable right or claim under this Twelfth Supplemental Indenture.

    

    

    [THE REMAINDER OF THIS PAGE IS INTENTIONALLY LEFT BLANK]

    

    

    
      - 4 -

      
        

    

    IN WITNESS WHEREOF, the parties hereto have caused this Twelfth Supplemental Indenture to be duly executed, all as of the date first written above.

    

    

    	 	
            NORTHROP GRUMMAN SYSTEMS CORPORATION

          
	 	 	 	 	 
	 	
            By:

          	/s/ Todd B. Ernst 

          	 
	 	 	
            Name:

          	
            Todd B. Ernst

          	 
	 	 	
            Title:

          	
            President and Treasurer

          	 
	 	 	 	 	 
	
            Attest:

          	 	 	 	 
	 	 	 	 	 
	 	
            By:

          	/s/ Jennifer C. McGarey 

          	 
	 	 	
            Name:

          	
            Jennifer C. McGarey

          	 
	 	 	
            Title:

          	
            Secretary

          	 

    

    

    

    

    

    

    

    

    

    

    
      [Signature Page to Twelfth Supplemental Indenture]

    

    
      
        

    

    

    

    	 	
            NORTHROP GRUMMAN CORPORATION

          
	 	 	 	 	 
	 	
            By:

          	/s/ Todd B. Ernst 

          	 
	 	 	
            Name:

          	
            Todd B. Ernst

          	 
	 	 	
            Title:

          	
            Corporate Vice President and Treasurer

          	 
	 	 	 	 	 
	
            Attest:

          	 	 	 	 
	 	 	 	 	 
	 	
            By:

          	/s/ Jennifer C. McGarey 

          	 
	 	 	
            Name:

          	
            Jennifer C. McGarey

          	 
	 	 	
            Title:

          	
            Corporate Vice President and Secretary

          	 

    

    

    

    

    

    

    

    

    
      [Signature Page to Twelfth Supplemental Indenture]

    

    
      
        

    

    

    

    	 	
            THE BANK OF NEW YORK MELLON,

            as Trustee

          
	 	 	 	 	 
	 	
            By:

          	/s/ Francine Kincaid

          	 
	 	 	
            Name:

          	Francine Kincaid 

          	 
	 	 	
            Title:

          	Vice President 

          	 
	 	 	 	 	 

    

    

    

    

    

    

    

    

    
      [Signature Page to Twelfth Supplemental Indenture]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00332-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00332-of-00352.parquet"}]]